Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
tesevatinib (KD019)
i
Other names:
KD-019, KD019 , XL647, XL 647, PRIM-001 , XL7647
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Sanofi
Drug class:
EGFR inhibitor, HER2 inhibitor, VEGFR inhibitor, EphB4 inhibitor
Related drugs:
‹
cetuximab (317)
osimertinib (240)
erlotinib (229)
afatinib (217)
gefitinib (183)
panitumumab (114)
lapatinib (105)
neratinib (102)
pyrotinib (64)
brigatinib (45)
icotinib (39)
aumolertinib (22)
amivantamab-vmjw (15)
BGB-283 (12)
furmonertinib (11)
lazertinib (9)
mobocertinib (7)
tarloxotinib bromide (7)
WZ4002 (7)
CH7233163 (6)
H002 (6)
ASLAN001 (6)
CL-387785 (5)
nimotuzumab (5)
rociletinib (5)
BDTX-189 (5)
AEE788 (4)
BDTX-1535 (4)
BI-4020 (4)
BLU-945 (4)
tomuzotuximab (4)
GB263T (4)
JIN-A02 (4)
TAS2940 (4)
EGF816 (4)
BBT-176 (3)
BLU-701 (3)
GC-1118A (3)
ASP8273 (3)
DZD9008 (3)
BCA101 (2)
BI-732 (2)
Bay846 (2)
MCLA-129 (2)
OBX02-011 (2)
olmutinib (2)
necitumumab (2)
QL1203 (2)
S95026 (2)
CLN-081 (2)
14aj (1)
ABN202 (1)
ABP 494 (cetuximab biosimilar) (1)
AFM24 (1)
APL-103 (1)
BLU-451 (1)
BPI-15086 (1)
BPI-361175 (1)
Compound 6a (1)
abivertinib (1)
ORIC-114 (1)
befotertinib (1)
TAS3351 (1)
S-222611 (1)
HMPL-813 (1)
ASK120067 (1)
MET306 (1)
SH-1028 (1)
HLX07 (1)
AZD3759 (1)
trastuzumab (369)
tucatinib (32)
trastuzumab-pkrb (23)
margetuximab (18)
poziotinib (16)
MCLA-128 (15)
KN026 (12)
trastuzumab-dttb (11)
ZW25 (10)
trastuzumab-anns (9)
trastuzumab-dkst (9)
trastuzumab-qyyp (9)
LZM-005 (8)
PRS-343 (8)
D3L-001 (7)
Zercepac (trastuzumab biosimilar) (7)
trastuzumab-IFN-β mutein (3)
inetetamab (2)
ER121 (2)
Her-VAXX (2)
trastuzumab/hyaluronidase-oysk (2)
JBJ-08–178–01 (2)
pertuzumab/trastuzumab/hyaluronidase-zzxf (2)
AB-201 (1)
ABL105 (1)
ACE1702 (1)
AST-301 (1)
Hercease (trastuzumab biosimilar) (1)
CT-0508 (1)
EG12014 (trastuzumab biosimilar) (1)
HERtiCAD (trastuzumab biosimilar) (1)
Hervelous (trastuzumab biosimilar) (1)
IMM2902 (1)
MP0274 (1)
SAR443216 (1)
TX05 (trastuzumab biosimilar) (1)
VRN101099 (1)
sunitinib (131)
lenvatinib (81)
axitinib (27)
fruquintinib (16)
cediranib (9)
TKI258 (9)
surufatinib (7)
MGCD265 (4)
E 3810 (4)
OMP-305B83 (3)
DC101 (1)
pasireotide (1)
CS 2164 (1)
X-82 (1)
sEphB4-HSA (5)
BHG712 (1)
cetuximab (317)
osimertinib (240)
erlotinib (229)
afatinib (217)
gefitinib (183)
panitumumab (114)
lapatinib (105)
neratinib (102)
pyrotinib (64)
brigatinib (45)
icotinib (39)
aumolertinib (22)
amivantamab-vmjw (15)
BGB-283 (12)
furmonertinib (11)
lazertinib (9)
mobocertinib (7)
tarloxotinib bromide (7)
WZ4002 (7)
CH7233163 (6)
H002 (6)
ASLAN001 (6)
CL-387785 (5)
nimotuzumab (5)
rociletinib (5)
BDTX-189 (5)
AEE788 (4)
BDTX-1535 (4)
BI-4020 (4)
BLU-945 (4)
tomuzotuximab (4)
GB263T (4)
JIN-A02 (4)
TAS2940 (4)
EGF816 (4)
BBT-176 (3)
BLU-701 (3)
GC-1118A (3)
ASP8273 (3)
DZD9008 (3)
BCA101 (2)
BI-732 (2)
Bay846 (2)
MCLA-129 (2)
OBX02-011 (2)
olmutinib (2)
necitumumab (2)
QL1203 (2)
S95026 (2)
CLN-081 (2)
14aj (1)
ABN202 (1)
ABP 494 (cetuximab biosimilar) (1)
AFM24 (1)
APL-103 (1)
BLU-451 (1)
BPI-15086 (1)
BPI-361175 (1)
Compound 6a (1)
abivertinib (1)
ORIC-114 (1)
befotertinib (1)
TAS3351 (1)
S-222611 (1)
HMPL-813 (1)
ASK120067 (1)
MET306 (1)
SH-1028 (1)
HLX07 (1)
AZD3759 (1)
trastuzumab (369)
tucatinib (32)
trastuzumab-pkrb (23)
margetuximab (18)
poziotinib (16)
MCLA-128 (15)
KN026 (12)
trastuzumab-dttb (11)
ZW25 (10)
trastuzumab-anns (9)
trastuzumab-dkst (9)
trastuzumab-qyyp (9)
LZM-005 (8)
PRS-343 (8)
D3L-001 (7)
Zercepac (trastuzumab biosimilar) (7)
trastuzumab-IFN-β mutein (3)
inetetamab (2)
ER121 (2)
Her-VAXX (2)
trastuzumab/hyaluronidase-oysk (2)
JBJ-08–178–01 (2)
pertuzumab/trastuzumab/hyaluronidase-zzxf (2)
AB-201 (1)
ABL105 (1)
ACE1702 (1)
AST-301 (1)
Hercease (trastuzumab biosimilar) (1)
CT-0508 (1)
EG12014 (trastuzumab biosimilar) (1)
HERtiCAD (trastuzumab biosimilar) (1)
Hervelous (trastuzumab biosimilar) (1)
IMM2902 (1)
MP0274 (1)
SAR443216 (1)
TX05 (trastuzumab biosimilar) (1)
VRN101099 (1)
sunitinib (131)
lenvatinib (81)
axitinib (27)
fruquintinib (16)
cediranib (9)
TKI258 (9)
surufatinib (7)
MGCD265 (4)
E 3810 (4)
OMP-305B83 (3)
DC101 (1)
pasireotide (1)
CS 2164 (1)
X-82 (1)
sEphB4-HSA (5)
BHG712 (1)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
EGFR amplification
Glioblastoma
EGFR amplification
Glioblastoma
KD019
Sensitive: C2 – Inclusion Criteria
KD019
Sensitive
:
C2
KD019
Sensitive: C2 – Inclusion Criteria
KD019
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login